Priority Setting in HIV, Tuberculosis, and Malaria - New Cost-Effectiveness Results From WHO-CHOICE

被引:8
作者
Ralaidovy, Ambinintsoa H. [1 ,2 ]
Lauer, Jeremy Addison [1 ,3 ]
Pretorius, Carel [4 ]
Briet, Olivier Jt [5 ,6 ]
Patouillard, Edith [1 ]
机构
[1] WHO, Geneva, Switzerland
[2] CERDI CNRS IRD UCA, Clermont Ferrand, France
[3] Univ Strathclyde, Glasgow, Lanark, Scotland
[4] Avenir Hlth, Glastonbury, CT USA
[5] Swiss Trop & Publ Hlth Inst, Basel, Switzerland
[6] Univ Basel, Basel, Switzerland
关键词
Cost-Effectiveness Analysis; HIV; Tuberculosis; Malaria; Priority Setting; Universal Health Coverage; MILLENNIUM DEVELOPMENT GOALS; IMPROVING HEALTH; STRATEGIES;
D O I
10.34172/ijhpm.2020.251
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: This paper forms part of an update of the World Health Organization Choosing Interventions that are Cost-Effective (WHO-CHOICE) programmes. It provides an assessment of global health system performance during the first decade of the 21st century (2000-2010) with respect to allocative efficiency in HIV, tuberculosis (TB) and malaria control, thereby shining a spotlight on programme development and scale up in these Millennium Development Goal (MDG) priority areas; and examining the cost-effectiveness of selected best-practice interventions and intervention packages commonly in use during that period. Methods: Generalized cost-effectiveness analysis (GCEA) was used to determine the cost-effectiveness of the selected interventions. Impact modelling was performed using the OpenMalaria platform for malaria and using the Goals and TIME (TB Impact Model and Estimates) models in Spectrum for HIV and TB. All health system costs, regardless of payer, were included and reported in international dollars. Health outcomes are estimated and reported as the gain in healthy life years (HLYs) due to the specific intervention or combination. Analysis was restricted to eastern sub-Saharan Africa and Southeast Asia. Results: At the reference year of 2010, commonly used interventions for HIV, TB and malaria were cost-effective, with cost-effectiveness ratios less than 1$ 100/HLY saved for virtually all interventions included. HIV, TB and malaria prevention and treatment interventions are highly cost-effective and can be implemented through a phased approach to full coverage to achieve maximum health benefits and contribute to the progressive elimination of these diseases. Conclusion: During the first decade of the 21st century (2000-2010), the global community has done well overall for HIV, TB, and malaria programmes as regards both economic efficiency and programmatic selection criteria. The role of international assistance, financial and technical, arguably was critical to these successes. As the global community now tackles the challenge of universal health coverage, this analysis can reinforce commitment to Sustainable Development Goal targets but also the importance of continued focus on these critical programme areas.
引用
收藏
页码:678 / 696
页数:19
相关论文
共 67 条
  • [1] [Anonymous], 2014, Final report of the WHO consultative group on equity and universal health coverage
  • [2] [Anonymous], 2017, VOL MED MAL CIRC HIV
  • [3] [Anonymous], 2013, Sixty-Sixth World Health Assembly
  • [4] [Anonymous], 2006, IMM COST FIN TOOL US
  • [5] [Anonymous], 2011, GOALS MAN MOD EST EF
  • [6] [Anonymous], 2010, GRADING GOALS SYSTEM
  • [7] [Anonymous], 2015, WHO End TB Strategy. Global Strategy and targets for tuberculosis prevention
  • [8] [Anonymous], 2012, GLOBAL BURDEN DIS ST
  • [9] [Anonymous], 2016, Sustainable consumption and production goal
  • [10] [Anonymous], 2016, HLTH SDGS ROL UN HLT